Pulmonary arterial hypertension associated with the use of interferon therapy for chronic hepatitis C infection complicated by extrinsic left main coronary artery compression

Internal Medicine Journal

Volumn 44, Issue 10, 2014, Pages 1027-1030

  Anderson, Robert D ^a   Thompson, A ^b   Burns, A T ^a  

^a Department of Cardiology ^*  (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Coronary artery compression; Hepatitis c infection; Interferon; Pulmonary hypertension

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMBRISENTAN; GAMMA GLUTAMYLTRANSFERASE; INTERFERON; PEGINTERFERON; RIBAVIRIN; ALPHA INTERFERON; ANTIVIRUS AGENT; PHENYLPROPIONIC ACID DERIVATIVE; PYRIDAZINE DERIVATIVE; VASODILATOR AGENT;

ADULT; AIRWAY OBSTRUCTION; ANTIVIRAL THERAPY; ARTERY COMPRESSION; ARTICLE; CASE REPORT; CENTRAL VENOUS PRESSURE; COMPUTED TOMOGRAPHY PULMONARY ANGIOGRAM; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY BLOOD FLOW; DECOMPENSATED RIGHT HEART FAILURE; DYSPNEA; ECHOCARDIOGRAPHY; ELASTOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TOLERANCE; FOLLOW UP; GENOTYPE; HEART CATHETERIZATION; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HEART SOUND; HEPATITIS C; HEPATOMEGALY; HUMAN; LEFT MAIN CORONARY ARTERY COMPRESSION; LIVER FIBROSIS; LIVER FUNCTION TEST; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; MALE; MEDICAL HISTORY; NEW YORK HEART ASSOCIATION CLASS; PERIPHERAL EDEMA; PULMONARY HYPERTENSION; SCHIZOPHRENIA; SYSTOLIC HEART MURMUR; THORAX PAIN; THROMBOCYTOPENIA; TRICUSPID VALVE REGURGITATION; VIRUS LOAD; CHEMICALLY INDUCED; CHEST PAIN; CORONARY STENOSIS; HEPATITIS C, CHRONIC; PATHOPHYSIOLOGY; PULMONARY ARTERY; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; CHEST PAIN; CORONARY STENOSIS; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION, PULMONARY; INTERFERON-ALPHA; MALE; PHENYLPROPIONATES; PULMONARY ARTERY; PYRIDAZINES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84913530896     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12554     Document Type: Article

References (8)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP etal. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54(1 Suppl): S43.
2. Dhillon S, Kaker A, Dosanjh A, Japra D, Van Thiel D. Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C. Dig Dis Sci 2010; 55: 1785-1790.
3. Fruehauf S, Steiger S, Topaly J, Ho AD. Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia. Ann Hematol 2001; 80: 308-310.
4. Irving WL, Day S, Johnston ID. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis 1993; 148: 1683-1684.
5. Matsumori A, Matoba Y, Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 1995; 92: 2519-2525.
6. Shiomi S, Kuroki T, Yokogawa T, Takeda T, Nishiguchi S, Nakajima S etal. Changes in results of Gallium-67-citrate scanning after interferon therapy for chronic hepatitis C. J Nucl Med 1997; 38: 216-219.
7. Demkow M, Kalińczuk Ł, Kepka C, Kurzyna M, Torbicki A. Left main artery compression by pulmonary artery aneurysm and ostial athero-stenosis of left anterior descending artery in a young female with pulmonary arterial hypertension. Eur Heart J 2012; 33: 2621.
8. Karrowni W, Sigurdsson G, Horwitz PA. Left main coronary artery compression by an enlarged pulmonary artery. JACC Cardiovasc Interv 2013; 6: e3-4.